182 related articles for article (PubMed ID: 33217488)
1. Ellagic acid ameliorates neuroinflammation and demyelination in experimental autoimmune encephalomyelitis: Involvement of NLRP3 and pyroptosis.
Kiasalari Z; Afshin-Majd S; Baluchnejadmojarad T; Azadi-Ahmadabadi E; Esmaeil-Jamaat E; Fahanik-Babaei J; Fakour M; Fereidouni F; Ghasemi-Tarie R; Jalalzade-Ogvar S; Khodashenas V; Sanaierad A; Zahedi E; Roghani M
J Chem Neuroanat; 2021 Jan; 111():101891. PubMed ID: 33217488
[TBL] [Abstract][Full Text] [Related]
2. Sinomenine Alleviates Murine Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis through Inhibiting NLRP3 Inflammasome.
Kiasalari Z; Afshin-Majd S; Baluchnejadmojarad T; Azadi-Ahmadabadi E; Fakour M; Ghasemi-Tarie R; Jalalzade-Ogvar S; Khodashenas V; Tashakori-Miyanroudi M; Roghani M
J Mol Neurosci; 2021 Feb; 71(2):215-224. PubMed ID: 32812186
[TBL] [Abstract][Full Text] [Related]
3. Ellagic acid protects from myelin-associated sphingolipid loss in experimental autoimmune encephalomyelitis.
Busto R; Serna J; Perianes-Cachero A; Quintana-Portillo R; García-Seisdedos D; Canfrán-Duque A; Paino CL; Lerma M; Casado ME; Martín-Hidalgo A; Arilla-Ferreiro E; Lasunción MA; Pastor Ó
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):958-967. PubMed ID: 29793057
[TBL] [Abstract][Full Text] [Related]
4. AZD8055 ameliorates experimental autoimmune encephalomyelitis via the mTOR/ROS/NLRP3 pathway.
He M; Wu DM; Zhao YY; Yu Y; Deng SH; Liu T; Zhang T; Li J; Wang F; Xu Y
Biochem Biophys Res Commun; 2021 Oct; 573():27-34. PubMed ID: 34384953
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the NLRP3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype.
Hou B; Zhang Y; Liang P; He Y; Peng B; Liu W; Han S; Yin J; He X
Cell Death Dis; 2020 May; 11(5):377. PubMed ID: 32415059
[TBL] [Abstract][Full Text] [Related]
6. Nicotinamide adenine dinucleotide treatment alleviates the symptoms of experimental autoimmune encephalomyelitis by activating autophagy and inhibiting the NLRP3 inflammasome.
Wang X; Li B; Liu L; Zhang L; Ma T; Guo L
Int Immunopharmacol; 2021 Jan; 90():107092. PubMed ID: 33290962
[TBL] [Abstract][Full Text] [Related]
7. Modulation of p38 MAPK and Nrf2/HO-1/NLRP3 inflammasome signaling and pyroptosis outline the anti-neuroinflammatory and remyelinating characters of Clemastine in EAE rat model.
Motawi TK; El-Maraghy SA; Kamel AS; Said SE; Kortam MA
Biochem Pharmacol; 2023 Mar; 209():115435. PubMed ID: 36720356
[TBL] [Abstract][Full Text] [Related]
8. Bixin Attenuates Experimental Autoimmune Encephalomyelitis by Suppressing TXNIP/NLRP3 Inflammasome Activity and Activating NRF2 Signaling.
Yu Y; Wu DM; Li J; Deng SH; Liu T; Zhang T; He M; Zhao YY; Xu Y
Front Immunol; 2020; 11():593368. PubMed ID: 33362775
[TBL] [Abstract][Full Text] [Related]
9. OLT1177 (Dapansutrile), a Selective NLRP3 Inflammasome Inhibitor, Ameliorates Experimental Autoimmune Encephalomyelitis Pathogenesis.
Sánchez-Fernández A; Skouras DB; Dinarello CA; López-Vales R
Front Immunol; 2019; 10():2578. PubMed ID: 31736980
[TBL] [Abstract][Full Text] [Related]
10. Amifostine ameliorates induction of experimental autoimmune encephalomyelitis: Effect on reactive oxygen species/NLRP3 pathway.
Li J; Wu DM; Yu Y; Deng SH; Liu T; Zhang T; He M; Zhao YY; Xu Y
Int Immunopharmacol; 2020 Nov; 88():106998. PubMed ID: 33182064
[TBL] [Abstract][Full Text] [Related]
11. S-allyl cysteine improves clinical and neuropathological features of experimental autoimmune encephalomyelitis in C57BL/6 mice.
Zeinali H; Baluchnejadmojarad T; Fallah S; Sedighi M; Moradi N; Roghani M
Biomed Pharmacother; 2018 Jan; 97():557-563. PubMed ID: 29101799
[TBL] [Abstract][Full Text] [Related]
12. The role of fatty acid binding protein 7 in spinal cord astrocytes in a mouse model of experimental autoimmune encephalomyelitis.
Kamizato K; Sato S; Shil SK; Umaru BA; Kagawa Y; Yamamoto Y; Ogata M; Yasumoto Y; Okuyama Y; Ishii N; Owada Y; Miyazaki H
Neuroscience; 2019 Jun; 409():120-129. PubMed ID: 31051217
[TBL] [Abstract][Full Text] [Related]
13. Inosine, an Endogenous Purine Nucleoside, Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis: a Role for A2A Adenosine Receptor.
Junqueira SC; Dos Santos Coelho I; Lieberknecht V; Cunha MP; Calixto JB; Rodrigues ALS; Santos ARS; Dutra RC
Mol Neurobiol; 2017 Jul; 54(5):3271-3285. PubMed ID: 27130268
[TBL] [Abstract][Full Text] [Related]
14. Targeted-Neuroinflammation Mitigation Using Inflammasome-Inhibiting Nanoligomers is Therapeutic in an Experimental Autoimmune Encephalomyelitis Mouse Model.
Sharma S; Risen S; Gilberto VS; Boland S; Chatterjee A; Moreno JA; Nagpal P
ACS Chem Neurosci; 2024 Apr; 15(7):1596-1608. PubMed ID: 38526238
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological inhibition of the NLRP3 inflammasome as a potential target for multiple sclerosis induced central neuropathic pain.
Khan N; Kuo A; Brockman DA; Cooper MA; Smith MT
Inflammopharmacology; 2018 Feb; 26(1):77-86. PubMed ID: 28965161
[TBL] [Abstract][Full Text] [Related]
16. Diosgenin ameliorates cellular and molecular changes in multiple sclerosis in C57BL/6 mice.
Zeinali H; Baluchnejadmojarad T; Roghani M
Mult Scler Relat Disord; 2021 Oct; 55():103211. PubMed ID: 34425463
[TBL] [Abstract][Full Text] [Related]
17. Gasdermin D in peripheral myeloid cells drives neuroinflammation in experimental autoimmune encephalomyelitis.
Li S; Wu Y; Yang D; Wu C; Ma C; Liu X; Moynagh PN; Wang B; Hu G; Yang S
J Exp Med; 2019 Nov; 216(11):2562-2581. PubMed ID: 31467036
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting the NLRP3 Inflammasome with MCC950 Alleviates Neurological Impairment in the Brain of EAE Mice.
Hou B; Yin J; Liu S; Guo J; Zhang B; Zhang Z; Yang L; Tan X; Long Y; Feng S; Zhou J; Wu Y; Wang X; Han S; Wang Z; He X
Mol Neurobiol; 2024 Mar; 61(3):1318-1330. PubMed ID: 37702910
[TBL] [Abstract][Full Text] [Related]
19. Protective and therapeutic role of 2-carba-cyclic phosphatidic acid in demyelinating disease.
Yamamoto S; Yamashina K; Ishikawa M; Gotoh M; Yagishita S; Iwasa K; Maruyama K; Murakami-Murofushi K; Yoshikawa K
J Neuroinflammation; 2017 Jul; 14(1):142. PubMed ID: 28732510
[TBL] [Abstract][Full Text] [Related]
20. IRAK-M suppresses the activation of microglial NLRP3 inflammasome and GSDMD-mediated pyroptosis through inhibiting IRAK1 phosphorylation during experimental autoimmune encephalomyelitis.
Wang Y; Pei S; Liu Z; Ding Y; Qian T; Wen H; Hsu SW; Zhou Z; Zhang J; Wang H
Cell Death Dis; 2023 Feb; 14(2):103. PubMed ID: 36765034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
